Pharmaceutical

Eleven and Novo Nordisk partner to develop nucleic acid therapeutics

The companies will develop new molecules using Eleven's innovative DELiveri platform to treat cardiometabolic diseases.

Jul 17, 2023 - 20:00
Eleven and Novo Nordisk partner to develop nucleic acid therapeutics
The companies will develop new molecules using Eleven's innovative DELiveri platform to treat cardiometabolic diseases.
Read the original article

Tags:

Previous Article

FDA expands Veklury’s use to Covid-19 patients with severe kidney disease

Next Article

SNIPR celebrates US court’s favourable ruling on CRISPR patent

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

With Ozempic, Wall Street moves on from a whole other class of medicines

With Ozempic, Wall Street moves on from a whole other c...

Oct 12, 2023

Incyte gets grant for treatment of various cancers usin...

Apr 5, 2024

Record number of respiratory syncytial virus (RSV) designations awarded in 2022

Record number of respiratory syncytial virus (RSV) desi...

Sep 9, 2023